搜索
诺和诺德
NVO添加自选
49.260USD
-1.170-2.32%
交易中 （美东）报价延迟15分钟
165.68B总市值
11.52市盈率 TTM
关于 诺和诺德 公司
诺和诺德是一家专注糖尿病护理的全球医疗健康公司，同时涉足药物的发现、研发、生产与行销。公司透过「糖尿病与肥胖护理」及「生物制药」两大业务运作。前者产品组合含胰岛素、GLP-1 受体激动剂（Ozempic、Wegovy、Rybelsus 等） 、胰高血糖素等蛋白质类疗法、蛋白质投递系统与注射针头，以及口服降糖药；后者聚焦血友病护理、生长激素补充及激素替代治疗。另有 Saxenda 专门针对临床肥胖症。主要品牌包含 NovoLog/NovoRapid、NovoLog Mix/NovoMix、Prandin/NovoNorm、NovoSeven、Norditropin、Vagifem 等。公司药品销往逾一百八十个国家，全球商业体系由北美与国际运营两大区域组成，透过临床研究、制造网络与市场渠道将疗法带给患者。
诺和诺德简介
公司代码NVO
公司名称Novo Nordisk A/S
上市日期May 17, 1974
CEODoustdar (Maziar Mike)
员工数量76302
证券类型Depository Receipt
年结日May 17
公司地址Novo Alle 1
城市BAGSVAERD
上市交易所NASDAQ OMX NASDAQ Basic NYSE
国家Denmark
邮编2880
电话4544448888
网址https://www.novonordisk.com/
公司代码NVO
上市日期May 17, 1974
CEODoustdar (Maziar Mike)
诺和诺德公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Lars Rebien Soerensen
Mr. Lars Rebien Soerensen
Chairman of the Board
Chairman of the Board
--
--
Ms. Liselotte Hyveled
Ms. Liselotte Hyveled
Director, Employee Representative
Director, Employee Representative
--
--
Mr. Maziar Mike Doustdar
Mr. Maziar Mike Doustdar
President, Chief Executive Officer
President, Chief Executive Officer
--
--
Mr. Henrik Ehlers Wulff
Mr. Henrik Ehlers Wulff
Executive Vice President - Product Supply
Executive Vice President - Product Supply
--
--
Mr. Kasim Kutay
Mr. Kasim Kutay
Director
Director
--
--
Ms. Mette Boejer Jensen
Ms. Mette Boejer Jensen
Director, Employee Representative
Director, Employee Representative
--
--
Mr. Thomas Rantzau
Mr. Thomas Rantzau
Director, Employee Representative
Director, Employee Representative
--
--
Mr. Karsten Munk Knudsen
Mr. Karsten Munk Knudsen
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Mr. Ludovic Helfgott
Mr. Ludovic Helfgott
Executive Vice President - Product & Portfolio Strategy
Executive Vice President - Product & Portfolio Strategy
--
--
Dr. Martin Holst Lange
Dr. Martin Holst Lange
Executive Vice President, Chief Scientific Officer, Research & Development
Executive Vice President, Chief Scientific Officer, Research & Development
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Lars Rebien Soerensen
Mr. Lars Rebien Soerensen
Chairman of the Board
Chairman of the Board
--
--
Ms. Liselotte Hyveled
Ms. Liselotte Hyveled
Director, Employee Representative
Director, Employee Representative
--
--
Mr. Maziar Mike Doustdar
Mr. Maziar Mike Doustdar
President, Chief Executive Officer
President, Chief Executive Officer
--
--
Mr. Henrik Ehlers Wulff
Mr. Henrik Ehlers Wulff
Executive Vice President - Product Supply
Executive Vice President - Product Supply
--
--
Mr. Kasim Kutay
Mr. Kasim Kutay
Director
Director
--
--
Ms. Mette Boejer Jensen
Ms. Mette Boejer Jensen
Director, Employee Representative
Director, Employee Representative
--
--
常见问题
诺和诺德的前五大股东是谁？
诺和诺德 的前五大股东如下：Mr. Lars Rebien Soerensen
有多少机构持有诺和诺德(NVO)的股份？
截至2026Q1，共有2975家机构持有诺和诺德的股份，合计持有的股份价值约为332.82M，占公司总股份的9.89%。与2025Q4相比，机构持股有所增加，增幅为-2714627.00。
哪个业务部门对诺和诺德的收入贡献最大？
在2026Q1，Total GLP-1业务部门对诺和诺德的收入贡献最大，创收23.00B，占总收入的49.25%。